Search Results
You searched for "Merck" ( 316 results )
-
GBC 2020 to discuss COVID-19 vaccine distribution
Biologics experts and industry officials will discuss accessibility of COVID-19 vaccines at the virtual Global Bio Conference 2020 starting Monday. According to the hosting Ministry of Food and Drug Safety, this year’s GBC is the sixth annual event and the first to open online. The Ministry anticipates participation from some 3,000 audience for the live broadcasts to be delivered by 61 speakers from 18 nations over three days. The number of speakers and partaking countries halved from
Industry Sept. 6, 2020
-
[Herald Interview] GI Innovation steadies IPO for 2021
GI Innovation is a fusion protein novel drug discovery firm that has made two license-out deals that are worth a combined $1.99 billion, just three years since its foundation. This feat for a small biotech comprising 50 employees has pinned GI Innovation as the next big catch in the health care sector after SK Biopharmaceuticals’ record-breaking initial public offering in June, which was 323 times oversubscribed. GI Innovation’s stock market listing on Kosdaq was previously antici
Industry Sept. 1, 2020
-
[Shang-Jin Wei] The US may lose in Trump’s TikTok war
Following US President Donald Trump’s vow to block US access to TikTok, the popular short-video app’s Chinese parent company ByteDance has been in frantic talks with Microsoft, presumably to sell its subsidiary quickly before the ban goes into effect. Of course, it is possible -- even likely –- that Trump’s real intent is not so much to ban TikTok as to force a fire sale to a US buyer. Trump has said that he wants the buyer to be “very American,” and has even
Viewpoints Aug. 11, 2020
-
Seoul stocks hit almost 2-year high on US stimulus hopes
South Korean stocks gathered ground for the third consecutive session on Wednesday to close at the highest level in nearly two years, as investor sentiment was buoyed by progress in US stimulus moves, analysts said. The Korean won rose against the greenback. The benchmark Korea Composite Stock Price Index (KOSPI) gained 31.89 points, or 1.4 percent, to finish at 2,311.86. Trading volume was high at 830 million shares worth 17.6 trillion won ($14.8 billion), with losers outpacing gainers 434 to
Market Aug. 5, 2020
-
Seoul stocks open higher on progress in US stimulus moves
South Korean stocks opened higher Wednesday, tracking overnight gains from Wall Street, as investor sentiment was buoyed by progress in US stimulus moves. The benchmark Korea Composite Stock Price Index (KOSPI) advanced 6.67 points, or 0.29 percent, to 2,286.64 in the first 15 minutes of trading. Overnight, the Dow Jones Industrial Average moved up 0.62 percent, while the tech-heavy Nasdaq Composite added 0.35 percent. US lawmakers have been making efforts to reach an agreement on new stimul
Market Aug. 5, 2020
-
Supplier of remdesivir’s API under sudden focus
When demand for facial masks surged, prescient investors immediately set their eyes on nonwoven fabric suppliers who manufacture the ingredients. Now, as remdesivir has been anointed as the only drug to be approved by the US Food and Drug Administration as an emergency COVID-19 treatment, investors are paying attention to what constitutes the riboneucleic acid drug. Remdesivir is a nucleoside analogue, or a nucleoside RNA polymerase inhibitor. If that sounds like alien talk, the FDA explains
Industry July 6, 2020
-
Merck starts next-gen semiconductor materials center in Korea
Global science and technology company Merck has opened the Korea Advanced Technology Center in Songtan Industrial Complex in Pyeongtaek, Gyeonggi Province, the company said Tuesday. “K-ATeC,” according to Merck, is a state-of-the-art facility that supports research and development for chemical mechanical polishing slurries as well as for the post-CMP cleaning of cutting-edge semiconductor devices. “Korea is an important innovation and production hub for Merck. We ha
Industry June 30, 2020
-
Merck launches integrated semiconductor solutions unit
Science and technology firm Merck announced Wednesday the launch of Performance Materials, a newly integrated body comprising of recently acquired US-based chemicals and materials firms and its existing semiconductor solutions unit. Merck had acquired Intermolecular, a California-based company for advanced materials innovation in September last year. The following month, Merck completed the acquisition of Versum Materials, an Arizona-based company and a major materials supplier to the semicondu
Industry June 3, 2020
-
Korean pharmas present latest findings at tumor forum
The fight against cancer is continuing despite the worldwide turmoil amid the coronavirus pandemic. The American Society of Clinical Oncology, the most authoritative annual gathering of anti-cancer drug researchers, chose to proceed with this year’s event online. The ASCO20 Virtual took place from May 29-31, inviting some 40,000 experts from over 70 countries to speak on various forms of tumors and the attempts to discover new, more advanced treatments for different types of cancer. Fr
Industry May 31, 2020
-
Samsung Bioepis’ breast cancer treatment biosimilar launches in US
Samsung Bioepis’ breast cancer treatment Ontruzant (trastuzumab) was launched in the US via local partner Merck, Thursday. Ontruzant references Roche’s blockbuster original Herceptin, which recorded annual global revenue of approximately 7.2 trillion won ($5.8 billion) in 2019. The US accounts for about 45 percent of Herceptin sales. Samsung Bioepis strategizes to sell Ontruzant at a 15 percent more affordable rate than Herceptin, as well as to offer doses of 150 milligrams and 4
Industry April 16, 2020
-
[News Analysis] Breakdown of drugs currently used to treat coronavirus
With experts suggesting that it will take one to five years for a vaccine for the new coronavirus to be developed from scratch, researchers are redirecting existing drugs and pipelines in an effort to control the outbreak. On Tuesday, Gilead Sciences’ Ebola treatment remdesivir was approved for a phase 3 clinical trial in South Korea by the Ministry of Food and Drug Safety. According to the clinical trial designed by Gilead Sciences, the efficacy of remdesivir on COVID-19 patients will
Industry March 3, 2020
-
Samsung Biologics to open first US entity by April
SAN FRANCISCO -- Samsung Biologics said Wednesday it will open a contract development (CDO) laboratory in San Francisco Bay Area by April, signaling its first expansion outside South Korea. Speaking on the company’s aggressive global expansion plans, Vice President John Rim, who accompanied CEO Kim Tae-han at the JP Morgan Healthcare Conference 2020 in San Francisco, said that the CDO lab in the US will place Samsung Biologics closer to potential partners with promising molecules. “T
Industry Jan. 16, 2020
-
[Weekender] Korea’s obsession with tallness
“I’m a 12-year-old girl and 158 centimeters tall. All my best friends are at least 160 centimeters in height. My goal is to eventually reach 180 centimeters. Please advise how I can grow taller.” The anonymous writer of the post on web portal Naver speaks for many others -- children and parents alike -- in their quest to stand above others, literally.The average height of Koreans was 170 centimeters for men and 157 centimeters for women in 2017, according to the national statis
Industry Jan. 16, 2020
-
Why going small is going big for Samsung Biologics
SAN FRANCISCO -- It may not be music to the ears of small and medium-sized contract manufacturing organizations, but Samsung Biologics said Tuesday it plans to expand its current business to cover smaller volumes. “We decided to add sCMO to our service for client satisfaction, to keep providing support to our contract development clients who need small batches of drug substance for their subsequent clinical phase one trials,” said Regina Choi-Rivera, head of the sCMO business unit at
Industry Jan. 15, 2020
-
Pharma firms flock to JP Morgan Healthcare Conference 2020
SAN FRANCISCO -- Samsung BioLogics CEO Kim Tae-han and Celltrion Chairman Seo Jung-jin are among the South Korean C-level officials making presentations at the 38th JP Morgan Healthcare Conference being held from Monday through Thursday. Both the executives have been invited to speak on Wednesday at the Grand Ballroom at the Westin St. Francis Hotel, that can accommodate some 800 people.Kim and Seo are joining the likes of global big pharma firms such as Bristol-Myers Squibb, Novartis, Merck, Ro
Technology Jan. 12, 2020
-
[Herald Interview] China’s No. 1 aesthetic laser firm sees Korea as bridge to Asian markets
Israeli company Alma Lasers, a leading player in China’s skin rejuvenation market, is undertaking an aggressive expansion into South Korea, viewing the country as a strategic market for its brand image. “Korea is a very important market. Being here is not only for revenue -- this is a market that we believe is a bridge to other markets in Asia,” said Lior Dayan, CEO of Sisram Medical, Alma’s parent company, in a conference call interview with The Korea Herald. “When
Industry Dec. 3, 2019
-
Samsung Bioepis gears up for approval of Avastin biosimilar in US
The clock has started ticking for the approval process of Samsung Bioepis’ fifth biosimilar in the US. The company said Wednesday that the US Food and Drug Administration has agreed to review the license application it submitted in September for SB8, a biosimilar candidate referencing Avastin (bevacizumab). Avastin is a blockbuster biologics drug of Roche that prevents tumor growth by blocking blood supply. It inhibits a protein called vascular endothelial growth factor that creates
Industry Nov. 20, 2019
-
Samsung Bioepis gains FDA approval for Humira biosimilar
Samsung Bioepis said Wednesday it has gained the US Food and Drug Administration’s approval for Hadlima, a biosimilar of AbbVie’s blockbuster autoimmune disease treatment Humira. This is the firm’s fourth biosimilar to get FDA approval, after Renflexis (Infliximab), Ontruzant (Trastuzumab) and Eticovo (Etanercept).Hadlima (adalimumab-bwwd) is developed by Samsung Bioepis and will be commercialized in the US by Merck from June 2023, according to a settlement with AbbVie.&nb
Industry July 24, 2019
-
[News Analysis] Why is Korea so dependent on Japanese materials?
The aggravating trade dispute with Japan reveals some hard truths about South Korea’s lack of basic technologies despite being dubbed as a tech powerhouse, not to mention the dire need to diversify its supply channels to reduce its heavy dependence on the neighboring nation. On July 1, the Japanese government tightened the export process to Korea of three classes of hi-tech materials crucial to the production of chips and display panels and removing it from the white list. The materials in
Industry July 11, 2019
-
Merck recruiting 18 startups for accelerator program
Biopharma company Merck said Thursday it is looking for 18 startups for its accelerator program in Darmstadt, Germany, and Shanghai, China. This round of participants will focus on four fields of research: biosensing and interfaces; liquid biopsy technologies; clean meat; and artificial intelligence-enabled health solutions. Merck will have 12 startups for its global headquarters in Darmstadt and six for the China Innovation Hub in Shanghai. It has hosted 57 startups since the accelerator p
Industry June 27, 2019
Most Popular
-
1
Tensions heighten ahead of first president-opposition chief meeting
-
2
Seoul to provide housing subsidy to married couples with newborns
-
3
[KH Explains] No more 'Michael' at Kakao Games
-
4
Rapper jailed after public street fight with another rapper
-
5
Woman gets suspended term for injuring boyfriend with knife
-
6
Samsung chief bolsters ties with Germany’s Zeiss
-
7
Nominee for chief of anti-corruption body pledges 'independence, effectiveness'
-
8
NewJeans pops out ‘Bubble Gum’ video amid troubles at agency
-
9
Med schools expect 1,500+ new admission slots next year
-
10
KT launches new mobile plans for foreign residents